Psoriasis Trials in Oceanside, United States
Conditions / Psoriasis / Oceanside, United States
Clinical trials for Psoriasis investigate a range of treatment strategies and patient populations.
12 total trials for this combination
Showing top 10 of 12 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01163253 | A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis | TERMINATED | PHASE3 |
| NCT03047395 | A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS ) | COMPLETED | PHASE3 |
| NCT00508547 | Psoriasis Longitudinal Assessment and Registry | ACTIVE_NOT_RECRUITING | — |
| NCT03090100 | A Study to Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis | COMPLETED | PHASE3 |
| NCT00678210 | Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis | COMPLETED | PHASE2 |
| NCT01646177 | A Study in Participants With Moderate to Severe Psoriasis (UNCOVER-3) | COMPLETED | PHASE3 |
| NCT01186744 | A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis | COMPLETED | PHASE3 |
| NCT00096928 | A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE) | COMPLETED | — |
| NCT02581345 | Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis | COMPLETED | PHASE3 |
| NCT00195676 | Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis | COMPLETED | PHASE3 |